Medicare Enrolled

Dr. Jeremiah Brown, MD

Ophthalmology · Schertz, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
17319 IH 35 N, Schertz, TX 78154
2106931063
In practice since 2006 (19 years)
NPI: 1891702163 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brown from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brown? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brown

Dr. Jeremiah Brown is an ophthalmology in Schertz, TX, with 19 years in practice. Based on federal Medicare data, Dr. Brown performed 28,417 Medicare services across 4,311 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brown received a total of $289,444 from 37 pharmaceutical and/or device companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brown is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in TX$ $289,444 industry payments

Medicare Practice Summary

Medicare Utilization ↗
28,417
Medicare services
Top 3% in TX for ophthalmology
4,311
Unique beneficiaries
$131
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,496 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)12,900$29$114
Retinal imaging (OCT scan)3,045$28$127
Aflibercept eye injection (Eylea)2,648$690$2,707
Eye injection for retinal disease2,488$83$374
Injection, ranibizumab, 0.1 mg2,417$179$775
Comprehensive eye exam, established patient1,223$83$395
Injection, pegcetacoplan, intravitreal, 1 mg1,080$120$451
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg976$212$833
Retinal photography (fundus photo)633$27$116
Comprehensive eye exam, new patient243$98$468
Injection, dexamethasone, intravitreal implant, 0.1 mg185$159$555
Compounded drug, not otherwise classified150$62$302
Exam of retinal blood vessels using a special camera after injection of a dye107$100$392
Unclassified drugs87$1,759$6,884
Destruction of leaking blood vessels of retina using laser43$243$1,051
Visual field test, extended40$44$196
Unclassified biologics26$1,921$7,230
Removal of membrane of retina with removal of internal limiting membrane of retina22$831$3,517
Removal of eye fluid (vitreous) between lens and retina20$675$2,761
Photocoagulation treatment to prevent detachment of retina20$176$752
2d ultrasound scan of eye tissue and structures15$31$151
Eye exam, established patient, focused14$59$280
Repair of detached retina with drainage and removal of eye fluid between lens and retina12$879$3,660
Optic nerve imaging (OCT scan)12$22$115
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional11$18$72
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$289,444
Total received (2018-2024)
Avg $41,349/year across 7 years
Top 1% in TX for ophthalmology
37
Companies
439
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$195,926 (67.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,696 (17.5%)
Other
Charitable contributions, space rental, and other categories
$25,541 (8.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,759 (3.4%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$7,522 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$99,458
2023
$35,575
2022
$39,226
2021
$36,672
2020
$7,132
2019
$31,163
2018
$40,217

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$128,648
Astellas Pharma US Inc
$36,774
US Retina LLC
$33,064
Apellis Pharmaceuticals, Inc.
$32,409
Genentech, Inc.
$20,769
Spark Therapeutics, Inc.
$19,531
EyePoint Pharmaceuticals US, Inc.
$2,539
Ocular Therapeutix, Inc.
$2,028
ABBVIE INC.
$1,960
Cardinal Health 108, LLC
$1,946
Allergan Inc.
$1,871
Carl Zeiss Meditec, Inc.
$1,821
Alimera Sciences, Inc.
$1,105
Regeneron Healthcare Solutions, Inc.
$949
Alcon Vision LLC
$700
Novartis Pharmaceuticals Corporation
$636
Harrow Eye, LLC
$373
Alcon Laboratories Inc
$325
Regeneron Pharmaceuticals, Inc.
$308
Biogen, Inc.
$273
Medline Industries LP
$193
BIOTISSUE HOLDINGS, INC.
$176
AbbVie Inc.
$147
Heidelberg Engineering, Inc.
$137
BIOTISSUE HOLDINGS INC.
$124
Amgen Inc.
$122
Mallinckrodt Hospital Products Inc.
$100
Dutch Ophthalmic, USA
$92
Carl Zeiss Meditec USA, Inc.
$89
Bausch & Lomb Americas Inc.
$62
MEDLINE INDUSTRIES LP
$43
Allergan, Inc.
$33
US Oncology Corporate, Inc.
$25
Bausch & Lomb, a division of Bausch Health US, LLC
$24
Carl Zeiss Meditec AG
$19
Horizon Therapeutics plc
$16
ANI Pharmaceuticals, Inc.
$14
Top 3 companies account for 68.6% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · BEOVU · BYOOVIZ · CLARUS · Constellation · DEXTENZA · DURYSTA · EVA Ophthalmic Surgical System · EYLEA · EYLEA HD · EYP-1901 · FF450plus · IHEEZO · ILUVIEN · Izervay · LUXTURNA · Lucentis · MIEBO · NGENUITY · None Specified · OZURDEX · PAZEO · PROKERA · PURIFIED CORTROPHIN GEL · SUSVIMO · SYFOVRE · Spectralis · Susvimo · Syfovre · TEPEZZA · VABYSMO · VISUDYNE · VUITY · Vabysmo · Wavelight · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for ophthalmology in TX.

Equivalent to $1,019 per 100 Medicare services performed
Looking for a ophthalmology in Schertz?
Compare ophthalmologys in the Schertz area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
168
Per 100K population
8.2
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
11.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Brown is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Brown experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Brown performed 12,900 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brown receive payments from pharmaceutical companies?
Yes. Dr. Brown received a total of $289,444 from 37 companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brown's costs compare to other ophthalmologys in Schertz?
Dr. Brown's average Medicare payment per service is $131. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brown) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →